If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTristel Regulatory News (TSTL)

Share Price Information for Tristel (TSTL)

Share Price is delayed by 15 minutes
Get Live Data
400.00    0.00 (0.00%)
Bid:
395.00
Ask:
405.00
Spread: 10.00 (2.532%)
Market Cap: £191.99m
TSTL Live PriceLast checked at - London Stock Exchange

Intraday Tristel Share Chart

Supply and Distribution Agree

23 Jun 2008 07:00

RNS Number : 2319X
Tristel PLC
23 June 2008
 



 

TRISTEL plc

Supply and distribution agreement with Bio-Cide International, Inc.United States, and representation in the Biocidal Products Directive

Tristel plc ("Tristel" or the "Group"), the AIM listed provider of infection and contamination control products, announces that it has entered into a new 20 year supply agreement with Bio-Cide International, Inc. ("BCI"), Oklahoma, United States. Additionally, Tristel has now been appointed as the distributor for BCI's products throughout the European Union. Tristel had previously been BCI's distributor only in the United Kingdom.

BCI is a manufacturer of a proprietary sodium chlorite solution, which is a key component in Tristel's chlorine dioxide products. BCI has been supplying its sodium chlorite chemistry to Tristel's legionella control and food contamination control subsidiary, Tristel Technologies, for over ten years. The enlarged relationship with BCI signals Tristel's intention to expand its legionella, food and horticulture contamination control business throughout Europe.

BCI is one of three industry partners that form the registration group for sodium chlorite/chlorine dioxide under the European Biocidal Products Directive ("BPD"), which is set to fashion the shape of the biocides industry in Europe. In conjunction with the new supply and distribution agreement, Tristel becomes BCI's representative within the BPD, placing Tristel at the heart of chlorine dioxide's future within the European marketplace.

For further information contact:

Tristel plc

Paul Swinney, Chief Executive

Tel: 01638 721 500

Daniel Stewart & Company Plc

Graham Webster

Tel: 020 7776 6576

Parkgreen Communications Ltd

Tel: 020 7479 7933

Paul McManus

Mob: 07980 541 893

paul.mcmanus@parkgreenmedia.com

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
AGRILFSERIIIFIT
Date   Source Headline
18th Jun 20159:00 amRNSDirector Dealing/Issue of Equity
18th Jun 20157:00 amRNSSpecial Dividend and notice of results
9th Jun 20151:44 pmRNSTristel welcomes Cardiff University wipes study
3rd Jun 201512:20 pmRNSIssue of Equity
22nd May 201511:19 amRNSIssue of Equity
21st May 20157:00 amRNSTrading update
8th May 20157:00 amRNSIssue of Equity
4th Mar 20157:00 amRNSIssue of Equity/Director dealing
26th Feb 20157:01 amRNSInvestor Presentation
25th Feb 20157:00 amRNSHalf Yearly Report
6th Feb 20157:00 amRNSInvestor Results Presentation
28th Jan 20157:00 amRNSIssue of Equity
24th Dec 201411:27 amRNSGrant of Share Options
23rd Dec 20142:38 pmRNSDirector/PDMR Shareholding
16th Dec 201411:53 amRNSResult of AGM
16th Dec 20147:00 amRNSAGM Statement
21st Nov 20147:00 amRNSPosting of Annual Report & Notice of AGM
17th Nov 20143:27 pmRNSIssue of Equity
11th Nov 20147:00 amRNSNZ ENT study shows Tristel Wipes System benefits
3rd Nov 20146:02 pmRNSDirector's Shareholding
20th Oct 201411:56 amRNSIssue of Equity
13th Oct 20147:00 amRNSFinal Results
29th Sep 20147:00 amRNSInvestor Results Presentation
19th Aug 20147:00 amRNSMarket leadership in UK ENT market
28th Jul 20147:00 amRNSPre-close trading update
7th Jul 201410:03 amRNSIssue of Equity
23rd Jun 20148:30 amRNSIssue of Equity
18th Jun 201411:16 amRNSHolding(s) in Company
10th Jun 20147:00 amRNSTrading Update
22nd May 201412:37 pmRNSIssue of Equity
28th Apr 20147:00 amRNSTrading update
24th Apr 20147:00 amRNSSuccess in controlling Clostridium difficile rates
13th Mar 20147:00 amRNSPublic Health England tackle disease threats
3rd Mar 20147:01 amRNSGrant of Share Options
3rd Mar 20147:00 amRNSHalf Yearly Report
13th Feb 20147:00 amRNSInvestor Results Presentation
22nd Jan 20147:00 amRNSTrading Update and notice of results
10th Dec 20132:14 pmRNSResult of AGM
10th Dec 20137:00 amRNSAGM Statement
15th Nov 20137:00 amRNSPosting of Annual Report & Notice of AGM
18th Oct 20137:00 amRNSPeer-reviewed published article
14th Oct 20137:00 amRNSFinal Results
22nd Jul 20137:00 amRNSTrading Update & Notice of Results
28th May 20132:19 pmRNSDirector/PDMR Shareholding
29th Apr 20132:53 pmRNSHolding(s) in Company
15th Apr 20131:47 pmRNSHolding(s) in Company
10th Apr 201311:45 amRNSHolding(s) in Company
9th Apr 201311:18 amRNSDirectors' Shareholdings
21st Mar 20132:44 pmRNSHolding(s) in Company
4th Mar 20139:28 amRNSDirector Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.